首页> 外国专利> A RAPID SEROLOGICAL TEST FOR PARATUBERCULOSIS USING FLUORESCENCE POLARIZATION TECHNOLOGY.

A RAPID SEROLOGICAL TEST FOR PARATUBERCULOSIS USING FLUORESCENCE POLARIZATION TECHNOLOGY.

机译:荧光偏振技术对寄生虫病的快速血清学检测。

摘要

The present invention provides an assay for detection of serum antibodies to M. paratuberculosis. A tracer, comprising a carbohydrate antigen isolated from M. paratuberculosis that is conjugated to a fluorophore, is added to a serum sample from an animal to form a mixture. The fluorescence polarization of the mixture is then measured. The presence of serum antibodies to M. paratuberculosis is indicated by a fluorescence polarization value of the mixture that is higher than the fluorescence polarization value of a control. The present invention further provides a tracer for use in a fluorescence polarization assay for antibodies specific for M. paratuberculosis. The tracer comprises a carbohydrate antigen isolated from M. paratuberculosis and conjugated to a fluorophore, such that the tracer is able to bind to antibodies specific for M. paratuberculosis to produce a detectable change in fluorescence polarization.The present invention provides an assay for detection of serum antibodies to iM. paratuberculosis/i. A tracer, comprising a carbohydrate antigen isolated from iM. paratuberculosis/i that is conjugated to a fluorophore, is added to a serum sample from an animal to form a mixture. The fluorescence polarization of the mixture is then measured. The presence of serum antibodies to iM. paratuberculosis/i is indicated by a fluorescence polarization value of the mixture that is higher than the fluorescence polarization value of a control. The present invention further provides a tracer for use in a fluorescence polarization assay for antibodies specific for iM. paratuberculosis/i. The tracer comprises a carbohydrate antigen isolated from iM. paratuberculosis/i and conjugated to a fluorophore, such that the tracer is able to bind to antibodies specific for iM. paratuberculosis/i to produce a detectable change in fluorescence polarization.
机译:本发明提供了用于检测抗副结核分枝杆菌的血清抗体的测定法。将包含从副结核分枝杆菌分离的碳水化合物抗原的示踪剂与荧光团偶联,将其添加到动物的血清样品中以形成混合物。然后测量混合物的荧光偏振。用比对照的荧光偏振值高的混合物的荧光偏振值来指示抗副结核分枝杆菌的血清抗体的存在。本发明进一步提供了一种示踪剂,用于对副结核分枝杆菌特异的抗体进行荧光偏振测定。该示踪剂包含从副结核分枝杆菌分离并结合至荧光团的碳水化合物抗原,从而该示踪剂能够结合对副结核分枝杆菌特异的抗体以产生可检测的荧光偏振变化。 M抗体。副结核病。示踪剂,其包含分离自M的碳水化合物抗原。与荧光团结合的副结核病被添加到动物的血清样品中以形成混合物。然后测量混合物的荧光偏振。存在针对M的血清抗体。通过混合物的荧光偏振值高于对照的荧光偏振值来表示副结核病。本发明进一步提供了用于荧光偏振测定的对M特异性抗体的示踪剂。副结核病。示踪剂包含从M中分离出的碳水化合物抗原。并结合到荧光团上,这样示踪剂就可以结合对M特异的抗体。副结核以产生可检测的荧光偏振变化。

著录项

  • 公开/公告号MXPA04003980A

    专利类型

  • 公开/公告日2004-11-29

    原文格式PDF

  • 申请/专利权人 DIACHEMIX LLC;

    申请/专利号MX2004PA03980

  • 发明设计人 KATHRYN IRENE STILWELL;

    申请日2002-10-31

  • 分类号A61K39/00;A61K39/02;A61K39/04;A61K39/38;A61K39/395;A61K39/40;C12Q1/00;G01N33/53;G01N33/531;G01N33/532;G01N33/566;

  • 国家 MX

  • 入库时间 2022-08-21 22:17:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号